GGrantIndex
← Leaderboards

John T. Isaacs

Johns Hopkins University

$6,502,533
Attributed
$6,502,533
Total exposure
7
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $286.1K · FY200520
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$6,502,533 · 7

By mechanism

P50$2,193,411 · 3
P30$1,676,758 · 1
R01$1,344,875 · 1
U54$670,455 · 1
T32$617,034 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Male

Research focus

MaleLaboratory MouseSeriesMalignant Neoplasm Of ProstateProstateProteinsLaboratoriesIn VivoMalignant NeoplasmsUniversitiesAndrogensPreventCancer CellDesignAblationGrowthCellsAndrogen ReceptorKillingsAnimal ColonyAnimal CareEffective TherapyBiomedical FacilityLaboratory Rat

Grant awards (32)

MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer$212,222
P50 · FY2020 · CA · contact PI
MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer$240,669
P50 · FY2018 · CA · contact PI
MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer$250,184
P50 · FY2017 · CA · contact PI
MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer$233,916
P50 · FY2016 · CA · contact PI
MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer$225,695
P50 · FY2015 · CA · contact PI
MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer$241,041
P50 · FY2014 · CA · contact PI
Full Project 3: Novel Bifunctional Anti-Andrgoens for Prostate Cancer$145,441
U54 · FY2010 · CA · contact PI
Full Project 3: Novel Bifunctional Anti-Andrgoens for Prostate Cancer$142,951
U54 · FY2009 · CA · contact PI
Full Project 3: Novel Bifunctional Anti-Andrgoens for Prostate Cancer$151,089
U54 · FY2008 · CA · contact PI
Full Project 3: Novel Bifunctional Anti-Andrgoens for Prostate Cancer$149,912
U54 · FY2007 · CA · contact PI
Full Project 3: Novel Bifunctional Anti-Andrgoens for Prostate Cancer$81,062
U54 · FY2006 · CA · contact PI
Targeting of the Androgen Receptor in Prostate Cancer$286,125
R01 · FY2005 · DK
Targeting of the Androgen Receptor in Prostate Cancer$286,125
R01 · FY2004 · DK
Targeting of the Androgen Receptor in Prostate Cancer$286,125
R01 · FY2003 · DK
Targeted activation of cytotoxic prodrugs by prostate specific proteases$0
P50 · FY2003 · CA
Targeting of the Androgen Receptor in Prostate Cancer$286,125
R01 · FY2002 · DK
Core--Animal Resources$250,404
P30 · FY2002 · CA
Core--Animal Resources$250,404
P30 · FY2002 · CA
DOWN REGULATION OF METASTASIS SUPPRESSOR GENE PREDICTING PROSTATE CANCER BEHAVIOR$131,614
P50 · FY2002 · CA
DOWN REGULATION OF METASTASIS SUPPRESSOR GENE PREDICTING PROSTATE CANCER BEHAVIOR$131,614
P50 · FY2002 · CA
GRADUATE PROGRAM IN CELLULAR AND MOLECULAR MEDICINE$333,252
T32 · FY2001 · GM
Core--Animal Resources$250,404
P30 · FY2001 · CA
Core--Animal Resources$250,404
P30 · FY2001 · CA
Core--Animal Resources$189,195
P30 · FY2001 · CA
DOWN REGULATION OF METASTASIS SUPPRESSOR GENE PREDICTING PROSTATE CANCER BEHAVIOR$131,614
P50 · FY2001 · CA
DOWN REGULATION OF METASTASIS SUPPRESSOR GENE PREDICTING PROSTATE CANCER BEHAVIOR$131,614
P50 · FY2001 · CA
CORE--ANIMAL RESOURCES$296,752
P30 · FY2000 · CA
GRADUATE PROGRAM IN CELLULAR AND MOLECULAR MEDICINE$283,782
T32 · FY2000 · GM
CELL/CELL INTERACTION AND PROSTATE GROWTH$200,375
R01 · FY2000 · DK
CORE--ANIMAL RESOURCES$189,195
P30 · FY2000 · CA
DOWN REGULATION OF METASTASIS SUPPRESSOR GENE PREDICTING PROSTATE CANCER BEHAVIOR$131,614
P50 · FY2000 · CA
DOWN REGULATION OF METASTASIS SUPPRESSOR GENE PREDICTING PROSTATE CANCER BEHAVIOR$131,614
P50 · FY2000 · CA